Welcome to the Feline Aortic Thromboembolism Clopidogrel vs Aspirin Trial (FATCAT)
Case enrollment is complete. No new cases are being accepted.
FATCAT is the first clinical trial examining the efficacy of clopidogrel (Plavix®) in preventing recurrence of feline aortic thromboembolism. This trial is being conducted by Dr. Dan Hogan at Purdue University and has been largely funded by the Morris Animal Foundation. The VIN Foundation is assisting Dr. Hogan with data collection. For future reference, we encourage you to bookmark this page.
Getting Started as a FATCAT Investigator:
The small print:
The FATCAT online system is hosted by VIN through support provided by the VIN Foundation. Similar to a growing list of veterinary online proceedings and journals, the FATCAT online system is hosted under VIN security. We wish to emphasize that there is NO REQUIREMENT OR ENCOURAGEMENT TO JOIN VIN. The VIN Foundation is a nonprofit 501(c)(3) corporation.Username and password.
If you do not have a username and password, you will need to complete a quick application which will allow you access to FATCAT. There is no requirement or encouragement to join VIN. The use of VIN security is to reduce the need for multiple username/password combinations for the majority of online veterinarians who already have access to VIN or VIN hosted online conference proceedings. You will only be allowed access to FATCAT. VIN will not distribute, or use the information you provide to access FATCAT in any way that is not associated with this study. If you wish to apply for a free VIN trial, you can do so from www.vin.com. If you experience technical difficulties, please contact VIN at 800.700.4636 or email VINGRAM@vin.com.Other stuff:
The study coordinators will determine patient eligibility after enrollment is complete.
email | 765-496-6743 | Fax: 765-496-1025
Copyright 2006, FATCAT